Cross-fund · 5 holders
ELVN
ENLIVEN THERAPEUTICS INC
CUSIP 29337E102
5
Tracked holders
$276.0M
Aggregate value
8,742,805
Shares
5
Active funds
Funds holding ELVN
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $144.4M | — | +71,381 | +2.0% |
| Citadel | Multi-Strategy | Q1 2026 | $73.4M | 0.01% | +429,471 | +29.8% |
| Vanguard | Institutional | Q4 2025 | $43.1M | — | +248,651 | +9.7% |
| Millennium | Multi-Strategy | Q1 2026 | $13.5M | 0.01% | +48,371 | +16.3% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $1.6M | — | -1,465,001 | -97.4% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.